API for the Exchange of Medicinal Product Information (APIX), published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/APIX---API-Exchange-for-Medicinal-Products/ and changes regularly. See the Directory of published versions
| Page standards status: Informative |
APIX replaces today's fragmented, procedure-specific exchange mechanisms with a single, unified API doorway for everything.
One FHIR interface covers every regulated product type and every regulatory procedure â eliminating per-procedure portal maintenance.
FedEx-style visibility across the entire portfolio. Every milestone is a timestamped event delivered via real-time subscriptions.
Machine-to-machine exchange enables automated validation, instant Q&A routing, and zero-delay decision delivery.
Once a regulator or company implements APIX, they gain the ability to receive, process, and exchange every regulatory interaction â across all product types (drugs, biologics, devices, veterinary) and all procedures â through the same single API interface.
| Stakeholder | Primary Benefit |
|---|---|
| Regulators | Auto-validation of submissions; removal of portal maintenance overhead; cross-domain visibility. |
| Industry (RA/IT) | Real-time status tracking; automated "push-button" submissions from RIM systems; unified submission pipe. |
| Patient Safety | Faster time-to-market for critical medicines; immediate safety signal synchronization; verified data integrity. |
Exchanging all regulatory activities for all products through a common standard.
Fragmented channels and proprietary systems for different product types increase complexity and costs.
A single, common way to exchange any regulatory activity for any product based on open web standards.
One platform, one interface, one standard for every regulated interaction across the entire lifecycle.
Eliminating the manual burden of high-volume variations.
Thousands of minor changes (Type IA/IB) consume vast resources in manual data entry and portal uploads.
Machine-to-machine exchange. RIM systems auto-compile and submit; regulators auto-validate and accept.
â80% reduction in submission preparation time. Zero increase in admin staff for massive volume growth.
Ending the "Black Box" of communication delays.
Information Requests arrive via email or static letters. Delays are invisible until deadlines are missed.
Questions arrive as actionable FHIR Tasks directly into workflow systems. Responses route back instantly via API.
â30% reduction in total "Clock Stop" duration. Full transparency for both sides.
Complete visibility across the portfolio.
Companies lack real-time visibility into where their submission sits in the agency's queue.
Unified status API. Every milestone triggers a real-time update visible in the company's dashboard.
â95% reduction in "where is my submission?" admin inquiries. Predictable product launches.
Document metadata is mapped to standardized IDMP identifiers for substances, products, organizations, and referentials, ensuring global data consistency.
Built on the same mature, universally-used technologies that power the global digital economy â leveraging robust, battle-tested tools from global banking and eCommerce.